Windtree Therapeutics Files 8-K: Material Agreement & Financials
Ticker: WINTW · Form: 8-K · Filed: Mar 24, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, regulation-fd
TL;DR
Windtree Therapeutics signed a new deal on 3/18/25, expect financial updates.
AI Summary
On March 18, 2025, Windtree Therapeutics, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company also made a Regulation FD disclosure and reported other events, including financial statements and exhibits. This filing pertains to Windtree Therapeutics, Inc., incorporated in Delaware.
Why It Matters
This 8-K filing indicates a significant new agreement for Windtree Therapeutics, potentially impacting its financial obligations and future operations.
Risk Assessment
Risk Level: medium — Material definitive agreements and financial disclosures can introduce uncertainty and impact stock price.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- March 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39290 (identifier) — SEC File Number
- 94-3171943 (identifier) — EIN
FAQ
What type of material definitive agreement did Windtree Therapeutics enter into?
The filing indicates the entry into a material definitive agreement, but the specific nature of the agreement is not detailed in the provided text.
What is the significance of the 'Creation of a Direct Financial Obligation' item?
This item signifies that the company has undertaken a new financial commitment or debt as a result of the reported events.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on March 18, 2025.
What is Windtree Therapeutics' former company name and when did the name change occur?
Windtree Therapeutics, Inc. was formerly known as Discovery Laboratories Inc. /DE/ and the name change occurred on December 1, 1997.
What is the SIC code for Windtree Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Windtree Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).